Accesso libero

Microwave ablation compared with radiofrequency ablation for the treatment of liver cancer: a systematic review and meta-analysis

Antonios E. Spiliotis
Antonios E. Spiliotis
, 
Gereon Gäbelein
Gereon Gäbelein
, 
Sebastian Holländer
Sebastian Holländer
, 
Philipp-Robert Scherber
Philipp-Robert Scherber
, 
Matthias Glanemann
Matthias Glanemann
 e 
Bijendra Patel
Bijendra Patel
   | 25 giu 2021
Radiology and Oncology's Cover Image
INFORMAZIONI SU QUESTO ARTICOLO
Articolo precedente
Articolo Successivo
Cita
Article Category: Review
Pubblicato online: 25 giu 2021
Pagine: 247 - 258
Ricevuto: 05 apr 2021
Accettato: 10 mag 2021
DOI: https://doi.org/10.2478/raon-2021-0030
© 2021 Antonios E. Spiliotis, Gereon Gäbelein, Sebastian Holländer, Philipp-Robert Scherber, Matthias Glanemann, Bijendra Patel, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Figure 1

Prisma flow diagram.MWA = microwave ablation, RFA = radiofrequency ablation, TACE = transarterial chemoembolization
Prisma flow diagram.MWA = microwave ablation, RFA = radiofrequency ablation, TACE = transarterial chemoembolization

Figure 2

Forest plot of random-effects meta-analysis results for complete ablation rates in the MWA and RFA group.CI = confidence interval, MWA = microwave ablation, OR = odds ratio, RFA = radiofrequency ablation
Forest plot of random-effects meta-analysis results for complete ablation rates in the MWA and RFA group.CI = confidence interval, MWA = microwave ablation, OR = odds ratio, RFA = radiofrequency ablation

Figure 3

Forest plot of random-effects meta-analysis results for local tumor progression in the RFA and MWA group.CI = confidence interval, MWA = microwave ablation, OR = odds ratio, RFA = radiofrequency ablation
Forest plot of random-effects meta-analysis results for local tumor progression in the RFA and MWA group.CI = confidence interval, MWA = microwave ablation, OR = odds ratio, RFA = radiofrequency ablation

Figure 4

Forest plot of random-effects meta-analysis results for local tumor progression in the RFA and MWA group based on the study type.CI = confidence interval, MWA = microwave ablation, OR = odds ratio, RFA = radiofrequency ablation
Forest plot of random-effects meta-analysis results for local tumor progression in the RFA and MWA group based on the study type.CI = confidence interval, MWA = microwave ablation, OR = odds ratio, RFA = radiofrequency ablation

Figure 5

Forest plot of random-effects meta-analysis results for intrahepatic distant recurrence rates in the RFA and MWA group.CI = confidence interval, MWA = microwave ablation, OR = odds ratio, RFA = radiofrequency ablation
Forest plot of random-effects meta-analysis results for intrahepatic distant recurrence rates in the RFA and MWA group.CI = confidence interval, MWA = microwave ablation, OR = odds ratio, RFA = radiofrequency ablation

Figure 6

Forest plot of random-effects meta-analysis results for complication rates following RFA and MWA.CI = confidence interval, MWA = microwave ablation, OR = odds ratio, RFA = radiofrequency ablation
Forest plot of random-effects meta-analysis results for complication rates following RFA and MWA.CI = confidence interval, MWA = microwave ablation, OR = odds ratio, RFA = radiofrequency ablation

Study and baseline characteristics of studies included in the meta-analysis

Study County Study Design Tumor RFA, n MWA, n Age, RFA Age, MWA Child-Pugh A/B/C, RFA Child-Pugh A/B/C, MWA Tumor size (cm), RFA Tumor size (cm), MWA Tumor lesions, RFA Tumor lesions, MWA
Kamal 2019 (13) Egypt RCT HCC 28 28 55 55 22.6.2000 22.6.2000 3.28 ± 0.91 3.25 ± 0.92 34 34
Vietti Violi 2018 (14) France/Switzerland RCT HCC 73 71 65 (median) 68 (median) 53/20/0 57/14/0 1.8 ± 0.71 1.8 ± 0.65 104 98
Abdelaziz 2014 (15) Egypt RCT HCC 45 66 56.8 ± 7.3 53.6 ± 5 24/21/0 25/41/0 2.95 ± 1.03 2.9 ± 0.97 52 76
Di Vece 2013 (16) Italy RCT HCC/Metastases 20 20 59 (median) 63 (median) N/R N/R 3.2 (median) 3.6 (median) 20 20
Qian 2012 (17) China Prospective HCC 20 22 56 ± 11 52 ± 12 20/0/0 22/0/0 2 ± 0.5 2.1 ± 0.4 20 22
Sparchez 2019 (18) Romania Retrospective Metastases 44 17 60.18 ± 9.96 62.12 ± 10.73 - - 2.maj feb.55 62 20
Takahashi 2018 (19) USA Retrospective CRLM 54 51 N/R N/R - - 2.4 (median) 2.1 (median) 155 121
Shady 2018 (20) USA Retrospective CRLM 62 48 N/R N/R - - 1.8 (median) 1.7 (median) 85 60
Xu 2017 (21) China Retrospective HCC 159 301 54 ± 11 54.2 ± 11 140/19/0 278/23/0 1.7 ± 0.3 1.7 ± 0.3 159 301
van Tilborg 2016 (38) Netherlands Retrospective CRLM Total number of participants: 122 N/R N/R - - 2.apr 2.maj 151 48
Potretzke 2016 (23) USA Retrospective HCC 55 99 62 61 N/R N/R 2.apr 2.feb 69 136
Zhang X. 2014 (24) China Retrospective HCC/Metastases 92 230 51.5 ± 14.3 55.7 ± 13.2 N/R N/R 5.4 ± 1.9 5.7 ± 2.1 173 349
Zhang L. 2013 (25) China Retrospective HCC 78 77 54 ± 10.5 54 ± 9.5 78/0/0 77/0/0 2.3 ± 0.4 2.2 ± 0.4 97 105
Liu 2013 (26) China Retrospective Metastases 54 35 53.1 ± 12.7 53.4 ± 15.3 - - 2.5 ± 1.0 2.3 ± 1.0 70 62
Ding 2013 (27) China Retrospective HCC 85 113 58.64 ± 8.52 59.06 ± 11.68 49/36/0 75/30/0 2.38 ± 0.81 2.55 ± 0.89 98 131
eISSN:
1581-3207
Lingua:
Inglese
Frequenza di pubblicazione:
4 volte all'anno
Argomenti della rivista:
Medicine, Clinical Medicine, Internal Medicine, Haematology, Oncology, Radiology
Feed RSS della rivista